Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Proposed Acquisition of European Medical Testing Subsidiary (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Sernova Corp > Exciting update!!
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12)
•••
Comment by Ekenbulletson Jan 26, 2022 2:12am
204 Views
Post# 34361006

RE:RE:RE:RE:RE:RE:Exciting update!!

RE:RE:RE:RE:RE:RE:Exciting update!!
Sailboatdream wrote:

 

Stockfshr wrote: Nobody is stopping you from moving on, Bio. Find a management you like. Or does one exist? Let us all know when you hit the road and best luck to you.

 

 

better yet... let's find a management we like and install them within SVA.  After communicating repeatedly with Dr. T during 2021, I am less than impressed with developments.  We may have much to thank him for for the past 13 years.  But this new phase of the company's growth may require a new ceo profile.



Well that will be very difficult. To say the least. What powers do you think we have here? Do we all toghether on this forum have like 1-2% of shares? If you want change you need to speak to the big fish

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities